Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Gothenburg, Sweden. 21 September 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces the launch of The Hidden Capacity Report, a new international report revealing significant opportunities to expand day surgery and help healthcare systems improve efficiency, increase surgical throughput and enhance patient outcomes.

Healthcare systems around the world face growing pressure to increase capacity while managing workforce constraints, financial pressures and rising demand for surgery. Day surgery offers one of the most effective opportunities to address these challenges by enabling clinically appropriate procedures to be performed safely without an overnight stay.
Advances in surgery, anesthesia, patient care and recovery pathways have made day surgery a viable option for an increasing number of procedures. Yet, despite strong evidence supporting day surgery1, adoption remains inconsistent across countries, healthcare organisations, specialties and individual clinical teams. Even in settings where day surgery is well established, there remains scope to make better use of available capacity as evidence, technologies and capabilities continue to evolve.
The Hidden Capacity Report explores the barriers, enablers and policy measures associated with expanding day surgery safely and at scale. The findings are based on a review of international literature, a survey of 256 healthcare professionals across ten countries, expert interviews and guidance from an international expert panel of key opinion leaders1.
Key findings:
Mr. David Bunting, Consultant in Upper Gastrointestinal and Abdominal Wall Reconstruction Surgery, North Devon District Hospital, United Kingdom, says:
“Our healthcare systems are now under huge pressure to deliver greater productivity with finite resources, whilst maintaining quality and safety of care with improved patient outcomes.
Day surgery is now well recognised as a solution to support elective recovery. It frees up in-patient beds for those with more acute medical needs or more complex surgical needs and improves hospital flow. Day surgery is also preferred by patients.”
Fredrik Wallefors, Executive Vice President Operating Room Solutions at Mölnlycke Health Care, says:
“Healthcare systems are under growing pressure to do more with less. The Hidden Capacity Report brings together evidence and expert insights to support the conversation on how safe, efficient and patient-centred day surgery pathways can help healthcare leaders make better use of existing resources while improving access to care.”
The report reflects Mölnlycke's commitment to supporting sustainable healthcare through evidence, innovation and collaboration. It is intended to stimulate dialogue with healthcare leaders, clinicians and policymakers on practical ways to improve healthcare system resilience, efficiency and patient outcomes.
Link to video interview with main author of The Hidden Capacity Report: https://youtu.be/cDFAKkcIFXE
The Hidden Capacity Report is available here:
For more information, please contact:

Media Relations
Email: jamie.smith@molnlycke.com
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.
UK’s Largest Hip and Knee Replacement Centre Becomes First in Scotland to Adopt Steriwave® Nasal Photodisinfection.
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
Gothenburg, Sweden. 8 June 2026. Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech, today confirmed a combined investment of approximately EUR 40 million in Mikkeli, Finland, and Oldham, UK. The investments strengthen the company’s global wound care manufacturing network by increasing capacity, optimising process quality and enhancing supply chain resilience and sustainability.
Gothenburg, Sweden, and Shanghai, China. 21 May 2026.
Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech and advanced wound care solutions, and Zhende Medical, a leading supplier of medical care and protection in China, today announce the formation of a new joint venture company in China to accelerate growth in one of the world’s fastest-growing wound care markets. The joint venture, majority-owned by Mölnlycke, will integrate the two companies’ wound care portfolios and commercial capabilities to offer healthcare providers, patients and the public expanded access to advanced treatments, improved care delivery and better patient outcomes across China.
Gothenburg, Sweden. 27 April 2026. A new study1 published in the Journal of Hospital Infection shows that introducing a simple glove change during caesarean birth could deliver millions in cost savings for the National Health Service (NHS) in England.
Gothenburg, Sweden. Wednesday 15 April 2026. Mölnlycke Health Care announces today the appointment of Andreas Johansson as Interim Chief Financial Officer (CFO), with immediate effect.
Gothenburg, Sweden. 1 April 2026. Today, Mölnlycke Health Care has published its annual report 2025, including sustainability report, outlining the company’s continued focus on revolutionising care for people and planet.
Gothenburg, Sweden. 31 March 2026. Mölnlycke®, a global leader in MedTech, today welcomes the publication of Shaping the future of wound care in Europe, the first joint industry white paper from the MedTech Europe Wound Care Sector Working Group. The wound paper highlights the growing burden of chronic wounds and urges EU policymakers to elevate wound care as a strategic health priority across the EU.